Related Experiment Videos
Infrared spectroscopy with statistical analysis and machine learning for cancer risk assessment in inflammatory bowel
Eric Kumi-Barimah1,2, Raneem Toman3, Animesh Jha1
1School of Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK. E.Kumi-Barimah@leeds.ac.uk.
Abstract:
Patients with inflammatory bowel disease (IBD) undergo regular colonoscopic surveillance due to their elevated risk of developing colorectal cancer (CRC). However, current clinical, endoscopic and histopathological risk stratification methods can be limited in sensitivity and objectivity, highlighting the need for complementary molecular approaches. In this study, Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR) was used to acquire mid-infrared (MIR) spectra from IBD-associated endoscopic biopsy samples (30 patients analysed; 10 who developed dysplastic pre-cancerous lesions and 20 who did not during long-term follow-up). Samples were stratified according to baseline clinical CRC risk (high/low) and subsequent pre-cancerous lesion development, enabling assessment of molecular signatures associated with future cancer risk rather than solely current disease status. Spectral variations were analysed using chemometric methods and machine learning classifiers. Principal component analysis (PCA) was performed to evaluate spectral separation, with the first three components (PC1, PC2 and PC3) accounting for 76.8%, 19.2% and 2.7% of the total variance, respectively. Hierarchical clustering analysis (HCA) further explored similarity patterns across defined spectral regions. Among the evaluated models, PLS-based classifiers achieved a balanced accuracy of 0.61-0.70 under repeated nested cross-validation; however, a permutation test indicated that this performance was not significantly above chance (p = 0.51), and no classifier significantly outperformed another. These findings indicate that ATR-FTIR-derived molecular fingerprints, particularly in the lipid-associated 2950-3030 cm-1 region, carry information associated with long-term CRC risk in IBD patients, but that a definitive classifier cannot be established from a cohort of this size; the approach is presented as a complementary, hypothesis-generating tool to conventional surveillance strategies.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Applications of IR Spectroscopy: Overview
Infrared (IR) Spectroscopy: Overview
Different compounds display unique properties due to their...